SCHEMBL28839717

SCHEMBL28839717

CSc1ccc(O)c(-c2ccccc2)c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 2/20 0.56
MCL1 Q07820 1/20 0.50
ALDH1A1 P00352 2/20 0.48
HPGD P15428 2/20 0.48
HSD17B10 Q99714 2/20 0.48
BCL2L1 Q07817 1/20 0.48
PELI1 Q96FA3 1/20 0.45
ALOX5 P09917 2/20 0.44
HSD17B1 P14061 1/20 0.44
HSD17B2 P37059 1/20 0.44
CHRM1 P11229 1/20 0.41
KDM4E B2RXH2 1/20 0.41
MEN1 O00255 1/20 0.41
USP2 O75604 1/20 0.41
LMNA P02545 1/20 0.41
HSP90AA1 P07900 1/20 0.41
GAA P10253 1/20 0.41
MAPT P10636 1/20 0.41
ALOX15 P16050 1/20 0.41
ALOX12 P18054 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9203397 0.85 PELI1 (0.46) BACE1MCL1PELI1ALOX5PTGS2
SCHEMBL3219906 0.84 BACE1 (0.60) BACE1MCL1ALDH1A1HPGDHSD17B10
SCHEMBL19259769 0.78 CHRM1 (0.42) BACE1MCL1HSD17B10CHRM1MEN1
SCHEMBL12042134 0.78 HSD17B1 (0.43) MCL1ALDH1A1HPGDHSD17B10HSD17B1
SCHEMBL3791154 0.77 ALDH1A1 (0.48) BACE1ALDH1A1HPGDHSD17B10CHRM1
SCHEMBL27523260 0.77 CHRM1 (0.41) BACE1MCL1HSD17B10CHRM1MEN1
SCHEMBL5634704 0.77 BACE1 (0.50) BACE1MCL1ALDH1A1HPGDHSD17B10
SCHEMBL14423572 0.76 BACE1 (0.46) BACE1MCL1ALDH1A1HPGDHSD17B10
SCHEMBL8441433 0.76 ALDH1A1 (0.58) BACE1ALDH1A1HPGDHSD17B10BCL2L1
Hydrochloric Acid SCHEMBL9311238 0.76 ALDH1A1 (0.47) BACE1ALDH1A1HPGDHSD17B10CHRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106459149-A Process for the liquid phase synthesis of h-inp-(d)bal-(d)trp-phe-apc-nh2, and pharmaceutically acceptable salts thereof 莫图斯治疗公司 2017-02-22 CN disclosed